Table 3.
nalB mutations and susceptibility to Ciprofloxacin in 16 isolates of P. aeruginosa.
| Sample | Nucleotide Mutation | Susceptibility to Ciprofloxacin |
|---|---|---|
| 1 | Transversion in nucleotide number 377, A → T/ | Resistant |
| 2 | Transition in nucleotide number 264 and 168, T → C and in nucleotide number 327, A → G / | Resistant |
| 3 | Transversion in nucleotide number 370, C → A / | Resistant |
| 4 | Transition in nucleotide number 327, A → G / | Resistant |
| 5 | Transversion in nucleotide number 377, A → T / | Resistant |
| 6 | Transition in nucleotide number 168, T → C / | Resistant |
| 7 | Transition in nucleotide number 168, T → C / | Resistant |
| 8 | Transition in nucleotide number 264 and 168, T → C and in nucleotide number 327, A → G / | Resistant |
| 9 | Transition in nucleotide number 327, A → G / | Susceptible |
| 10 | Transition in nucleotide number 168, T → C / | Resistant |
| 11 | Transition in nucleotide number 327, A → G and Transversion in nucleotide number 377, A → T / | Resistant |
| 12 | Transition in nucleotide number 264 and 168, T → C and in nucleotide number 327, A → G / | Resistant |
| 13 | Transition in nucleotide number 223 T → C and in nucleotide number 327, A → G / | Resistant |
| 14 | Transition in nucleotide number 327, A → G and Transversion in nucleotide number 377, A → T / | Susceptible |
| 15 | Transition in nucleotide number 168, T → C and in nucleotide number 264, T → C and in nucleotide number 329, A → G / | Resistant |
| 16 | Transition in nucleotide number 166 and 262, T → C and in nucleotide number 325, A→ G / | Susceptible |